HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anthony J Furlan Selected Research

Therapeutics

12/2021Heterogeneity of Treatment Effects in an Analysis of Pooled Individual Patient Data From Randomized Trials of Device Closure of Patent Foramen Ovale After Stroke.
3/2016Device Closure of Patent Foramen Ovale After Stroke: Pooled Analysis of Completed Randomized Trials.
1/2016Acute Stroke Imaging Research Roadmap III Imaging Selection and Outcomes in Acute Stroke Reperfusion Clinical Trials: Consensus Recommendations and Further Research Priorities.
12/2015Acute Ischemic Stroke Therapy: The Way Forward.
9/2015Anticoagulant vs. antiplatelet therapy in patients with cryptogenic stroke and patent foramen ovale: an individual participant data meta-analysis.
6/2015Endovascular therapy for stroke--it's about time.
12/2014Early reperfusion and clinical outcomes in patients with M2 occlusion: pooled analysis of the PROACT II, IMS, and IMS II studies.
8/2014Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.
4/2014A double-blind placebo-controlled clinical evaluation of MultiStem for the treatment of ischemic stroke.
9/2013Patent foramen ovale and cryptogenic stroke: the hole story.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Anthony J Furlan Research Topics

Disease

38Stroke (Strokes)
01/2022 - 01/2002
29Ischemic Stroke
01/2022 - 01/2002
7Patent Foramen Ovale
03/2016 - 12/2010
4Transient Ischemic Attack
08/2014 - 12/2010
3Paradoxical Embolism
12/2021 - 12/2010
3Intracranial Hemorrhages (Intracranial Hemorrhage)
01/2018 - 03/2003
2Infarction (Infarctions)
01/2018 - 08/2003
2Myocardial Infarction
11/2017 - 04/2014
2Cerebral Hemorrhage
01/2010 - 08/2003
2Hypotension (Low Blood Pressure)
09/2003 - 08/2002
1Aneurysm (Aneurysms)
12/2021
1Hypertension (High Blood Pressure)
01/2015
1Graft vs Host Disease (Graft-Versus-Host Disease)
04/2014
1Brain Infarction
12/2012
1Pathologic Constriction (Stenosis)
06/2012
1Neurologic Manifestations (Neurological Manifestations)
12/2010
1Atrial Fibrillation
04/2010
1Thrombosis (Thrombus)
06/2008
1Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
05/2003
1Hemorrhagic Stroke
09/2002
1Brain Ischemia (Cerebral Ischemia)
08/2002
1Wounds and Injuries (Trauma)
08/2002

Drug/Important Bio-Agent (IBA)

8Tissue Plasminogen Activator (Alteplase)FDA Link
01/2022 - 09/2002
5Desmodus rotundus salivary plasminogen activator alpha 1IBA
09/2012 - 05/2006
2Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2022 - 05/2009
2Neuroprotective AgentsIBA
12/2012 - 08/2003
2saruplaseIBA
05/2003 - 01/2002
1Clopidogrel (Plavix)FDA Link
01/2022
1antineoplaston A10 (A 10)IBA
12/2021
1LipidsIBA
11/2017
1Antihypertensive Agents (Antihypertensives)IBA
11/2017
1APTIBA
09/2015
1AnticoagulantsIBA
09/2015
1Blood Glucose (Blood Sugar)IBA
01/2015
1Complement System Proteins (Complement)IBA
01/2014
1Warfarin (Coumadin)FDA LinkGeneric
05/2009
1Plasminogen Activators (Plasminogen Activator)IBA
02/2009
1Abciximab (ReoPro)FDA Link
06/2008
1Pharmaceutical PreparationsIBA
08/2005
1Nitric Oxide Synthase (NO Synthase)IBA
09/2003
1Fibrinolytic Agents (Antithrombotic Agents)IBA
08/2003
1Contrast MediaIBA
08/2003
16-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA
08/2002
1Carbon DioxideIBA
08/2002
1Adenosine Diphosphate (ADP)IBA
08/2002
1Heparin (Liquaemin)FDA LinkGeneric
06/2002

Therapy/Procedure

26Therapeutics
12/2021 - 01/2002
9Thrombectomy
01/2022 - 11/2009
3Stents
01/2022 - 06/2008
2Thrombolytic Therapy
08/2003 - 06/2002
1Patient Care Bundles
01/2016
1Secondary Prevention
09/2015
1Combined Modality Therapy
12/2012
1Catheter Ablation
04/2010
1Time-to-Treatment
08/2003
1Anesthesia
08/2002